Open Access
MolBank, volume 2021, issue 4, pages M1295
4,7-bis(1,2,3,4,4a,9a-hexahydro-9h-carbazol-9-yl)-[1,2,5]oxadiazolo[3,4-d]pyridazine
Publication type: Journal Article
Publication date: 2021-11-05
DOI:
10.3390/M1295
Organic Chemistry
Biochemistry
Physical and Theoretical Chemistry
Abstract
New donor-acceptor-donor (D-A-D)-type structures are widely used to design effective organic light-emitting diodes (OLEDs). In this communication, 4,7-bis(1,2,3,4,4a,9a-hexahydro-9H-carbazol-9-yl)-[1,2,5]oxadiazolo[3,4-d]pyridazine was obtained in a 65% yield by the treatment of 4,7-dichloro[1,2,5]oxadiazolo[3,4-d]pyridazine 1-oxide with 2,3,4,4a,9,9a-hexahydro-1H-carbazole. The structure of the newly synthesized compounds was established by means of an elemental analysis, 1H, 13C NMR, IR and UV spectroscopy, and HRMS and LR mass-spectrometry.
Citations by journals
1
2
|
|
MolBank
|
MolBank
2 publications, 100%
|
1
2
|
Citations by publishers
1
2
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
2 publications, 100%
|
1
2
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
{"yearsCitations":{"type":"bar","data":{"show":true,"labels":[2022,2023],"ids":[0,0],"codes":[0,0],"imageUrls":["",""],"datasets":[{"label":"Citations number","data":[1,1],"backgroundColor":["#3B82F6","#3B82F6"],"percentage":["50","50"],"barThickness":null}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"journals":{"type":"bar","data":{"show":true,"labels":["MolBank"],"ids":[20017],"codes":[0],"imageUrls":["\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp"],"datasets":[{"label":"","data":[2],"backgroundColor":["#3B82F6"],"percentage":[100],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Journals","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"publishers":{"type":"bar","data":{"show":true,"labels":["Multidisciplinary Digital Publishing Institute (MDPI)"],"ids":[202],"codes":[0],"imageUrls":["\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp"],"datasets":[{"label":"","data":[2],"backgroundColor":["#3B82F6"],"percentage":[100],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Publishers","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}}}
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Chmovzh T. N. et al. 4,7-bis(1,2,3,4,4a,9a-hexahydro-9h-carbazol-9-yl)-[1,2,5]oxadiazolo[3,4-d]pyridazine // MolBank. 2021. Vol. 2021. No. 4. p. M1295.
GOST all authors (up to 50)
Copy
Chmovzh T. N., Gaisin K. S., Rakitin O. A. 4,7-bis(1,2,3,4,4a,9a-hexahydro-9h-carbazol-9-yl)-[1,2,5]oxadiazolo[3,4-d]pyridazine // MolBank. 2021. Vol. 2021. No. 4. p. M1295.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3390/M1295
UR - https://doi.org/10.3390%2FM1295
TI - 4,7-bis(1,2,3,4,4a,9a-hexahydro-9h-carbazol-9-yl)-[1,2,5]oxadiazolo[3,4-d]pyridazine
T2 - MolBank
AU - Chmovzh, Timofey N
AU - Gaisin, Karim S
AU - Rakitin, Oleg A.
PY - 2021
DA - 2021/11/05 00:00:00
PB - Multidisciplinary Digital Publishing Institute (MDPI)
SP - M1295
IS - 4
VL - 2021
SN - 1422-8599
ER -
Cite this
BibTex
Copy
@article{2021_Chmovzh
author = {Timofey N Chmovzh and Karim S Gaisin and Oleg A. Rakitin},
title = {4,7-bis(1,2,3,4,4a,9a-hexahydro-9h-carbazol-9-yl)-[1,2,5]oxadiazolo[3,4-d]pyridazine},
journal = {MolBank},
year = {2021},
volume = {2021},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
month = {nov},
url = {https://doi.org/10.3390%2FM1295},
number = {4},
pages = {M1295},
doi = {10.3390/M1295}
}
Cite this
MLA
Copy
Chmovzh, Timofey N., et al. “4,7-bis(1,2,3,4,4a,9a-hexahydro-9h-carbazol-9-yl)-[1,2,5]oxadiazolo[3,4-d]pyridazine.” MolBank, vol. 2021, no. 4, Nov. 2021, p. M1295. https://doi.org/10.3390%2FM1295.